Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

IsoRay receives FDA clearance for GliaSite radiation therapy system to treat brain cancer

IsoRay, Inc. announced today that the FDA has cleared its GliaSite radiation therapy system, a balloon catheter device used in the treatment of brain cancer.

12 Sep 2011

ASTRO, Cancer Support Community Greater Miami partner to raise awareness on survivorship issues

As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is partnering with the Cancer Support Community Greater Miami to raise awareness of cancer survivorship issues.

9 Sep 2011

Stage III lung cancer patients can benefit from concurrent chemo and radiation therapy

Nearly 50,000 Americans are diagnosed each year with stage III or locally advanced NSCLC, for which surgery is usually not a viable treatment option. Optimizing nonsurgical treatment strategies for these patients is an ongoing research endeavor.

9 Sep 2011

Pathology Visions Conference to be held at Manchester Grand Hyatt in San Diego

Mahul B. Amin, MD, chair of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, will offer his perspectives and expertise on personalized medicine and digital pathology at the 2011 Pathology Visions Conference.

3 Sep 2011

Researchers discover mechanisms behind BRCA1 gene mutations in breast and ovarian cancer

It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers at Virginia Commonwealth University Massey Cancer Center have shown that certain BRCA1 mutations result in excessive, uncontrolled DNA repair, which challenges the prior assumption that mutations in BRCA1 only contribute to breast cancer through a reduction in function.

3 Sep 2011

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

Half-matched bone marrow or stem cell transplants for blood cancer patients have typically been associated with disappointing clinical outcomes. However, a clinical trial conducted at the Kimmel Cancer Center at Jefferson testing its unique, two-step half-match procedure has produced some promising results: the probability of overall survival was 45 percent in all patients after three years and 75 percent in patients who were in remission at the time of the transplant.

2 Sep 2011

ASTRO's 53rd Annual Meeting to highlight new cancer advances in Miami

Who: The American Society for Radiation Oncology (ASTRO) - the world's largest radiation oncology society in the world, with more than 10,000 members who use radiation to treat cancer and other diseases.

2 Sep 2011

RI Hospital researcher supports use of ablation procedures for treatment of lung cancer

The journal Radiology will publish in its September issue an article written by Damian E. Dupuy, M.D., director of tumor ablation at Rhode Island Hospital, supporting the use of ablation procedures for the treatment of lung cancer.

2 Sep 2011

New implantable micro oxygen generator improves effectiveness of anticancer tharapy

Researchers have created and tested miniature devices that are implanted in tumors to generate oxygen, boosting the killing power of radiation and chemotherapy.

2 Sep 2011

Valproic acid may increase survival for brain tumor patients

New research suggests brain tumor patients who take the seizure drug valproic acid on top of standard treatment may live longer than people who take other kinds of epilepsy medications to control seizures.

2 Sep 2011

Prostate cancer linked to pesticides: Study

Researchers at the University of Southern California (USC) have found an increased prevalence of prostate cancer among older men exposed to certain pesticides in Central Valley neighborhoods.

31 Aug 2011

RaySearch Laboratories reports net sales of SEK 47.6 M for January 1 - June 30, 2011

RaySearch Laboratories: JANUARY 1 - JUNE 30, 2011. Net sales for the period totaled SEK 47.6 M.

30 Aug 2011

Magnetic resonance imaging may predict survival in patients with advanced rectal cancer

A new study has shown that magnetic resonance imaging (MRI) used to evaluate responses to pre-surgery (neo-adjuvant) chemotherapy or radiation may predict survival among patients with advanced rectal cancer.

30 Aug 2011

LWW receives 11 Apex Awards for Publication Excellence Competition

Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, is pleased to announce that seven LWW published journals have won 11 highly regarded awards in this year's Apex Awards for Publication Excellence Competition, recognizing publishing excellence in a variety of categories. Emergency Medicine News took home the esteemed Grand Award for Excellence in the category of 'Magapapers & Newspapers.'

26 Aug 2011

US Oncology Research earns RTOG's Full Member status

US Oncology Research, one of the nation's largest networks of community-based researchers, and Radiation Therapy Oncology Group (RTOG), the leader in radiation oncology-focused clinical trials in the United States, announced today that US Oncology Research has earned Full Member status, an accomplishment few institutions achieve.

25 Aug 2011

Health Quest Systems selects RayStation for advanced treatments

RaySearch Laboratories AB has received an order for its RayStation treatment planning system from Health Quest Systems, Inc., headquartered in LaGrange, New York.

24 Aug 2011

IsoRay Cs-131 mesh brachytherapy with da Vinci Robot for lung cancer treatment gains momentum

IsoRay, Inc. said today that a growing number of hospitals and medical treatment centers are adopting its proprietary mesh Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy) for use in conjunction with the da Vinci® Surgical System to treat early stage lung cancer patients. One of the most recent adopters is Georgia's Archbold Memorial Hospital.

23 Aug 2011

Radiation Therapy News and Research

Further Reading

IsoRay receives FDA clearance for GliaSite radiation therapy system to treat brain cancer

ASTRO, Cancer Support Community Greater Miami partner to raise awareness on survivorship issues

Stage III lung cancer patients can benefit from concurrent chemo and radiation therapy

Pathology Visions Conference to be held at Manchester Grand Hyatt in San Diego

Researchers discover mechanisms behind BRCA1 gene mutations in breast and ovarian cancer

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

ASTRO's 53rd Annual Meeting to highlight new cancer advances in Miami

RI Hospital researcher supports use of ablation procedures for treatment of lung cancer

New implantable micro oxygen generator improves effectiveness of anticancer tharapy

Valproic acid may increase survival for brain tumor patients

Prostate cancer linked to pesticides: Study

RaySearch Laboratories reports net sales of SEK 47.6 M for January 1 - June 30, 2011

Magnetic resonance imaging may predict survival in patients with advanced rectal cancer

LWW receives 11 Apex Awards for Publication Excellence Competition

US Oncology Research earns RTOG's Full Member status

Health Quest Systems selects RayStation for advanced treatments

IsoRay Cs-131 mesh brachytherapy with da Vinci Robot for lung cancer treatment gains momentum

Advanced ROS selects RayStation for conventional 3D-CRT treatments

CEL-SCI receives Chinese patent for Multikine cancer drug

Curis initiates CUDC-101 Phase I combination trial in advanced head and neck cancer

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News